title: Emergence of hepatitis B infection despite antibodies to hepatitis B surface antigen: a new nosocomial risk in patients with end-stage renal disease.
authors.forename: Valérie
authors.initials: V
authors.lastname: Moal
authors.forename: Henri
authors.initials: H
authors.lastname: Vacher-Coponat
authors.forename: Elisabeth
authors.initials: E
authors.lastname: Botelho
authors.forename: Yvon
authors.initials: Y
authors.lastname: Berland
authors.forename: Philippe
authors.initials: P
authors.lastname: Colson
authors.forename: Catherine
authors.initials: C
authors.lastname: Tamalet
authors.forename: Mireille
authors.initials: M
authors.lastname: Henry
mesh_terms: D000914:Antibodies, Viral / Q000276:immunology*; D003428:Cross Infection / Q000453:epidemiology / Q000276:immunology*; D005602:France / Q000453:epidemiology; D006509:Hepatitis B / Q000276:immunology*; D006511:Hepatitis B Antigens / Q000276:immunology*; D017325:Hepatitis B Vaccines; D006801:Humans; D015994:Incidence; D007676:Kidney Failure, Chronic / Q000276:immunology*; D006435:Renal Dialysis / Q000009:adverse effects; D012307:Risk Factors
chemical_list: D000914:Antibodies, Viral; D006511:Hepatitis B Antigens; D017325:Hepatitis B Vaccines